in 2024 trust the "experts" or trust our chaps :(77% differential) :)
nai |
Happy international StarWars day everybody. May the 4th be with you and all that.
OXB try to avoid 3rd parties for recruitment. You can see what they are looking for at any particular time via that link on their website
11 at the moment.
Kingzog wins the prize for getting post 7777. |
Has anyone here still been topping up since we headed above 3 quid...someone must have been buying :) |
''The scope of recruitment will include from junior to director level roles.'' |
 OXB embarking on a hiring spree for numerous roles, from 'toilet cleaner' to Director. Expansion no doubt in expectation of volume led work as per ''Build Talent Pools for specific high volume roles'' :
Talent Acquisition (Recruitment) Specialist
Oxford BioMedica (UK) Limited
OXFORD
Salary - To define
Start date - 3 May 2024
Closing date - 31 May 2024
Job description:
We are currently recruiting for a Talent Acquisition Specialist to join the Human Resources team, initially for a 12 month fixed term contract. The purpose of this role is to partner closely with assigned senior level stakeholders, acting as an advisor and taking ownership for the end-to-end recruitment lifecycle, from recruitment briefing meeting, advertising, sourcing, arranging interviews and making job offers, negotiating and agreeing final packages. The scope of recruitment will include from junior to director level roles.
Your responsibilities in this role would be:
For assigned roles, you will manage the end-to-end recruitment process. This includes:
Conduct a Recruitment Briefing Meeting with the Hiring Manager to ensure an understanding of the requirements of the vacancy and the interview process, providing guidance on the current candidate market place
Source
Develop job adverts to post and advertise vacancies
Search and ‘headhunt’ candidates directly for niche roles
Build Talent Pools for specific high volume roles
Promote the Employee Referral program and encourage internal development and movement
Advertise on LinkedIn and JobBoards, promoting the Employee Value Proposition
cont...... |
On for one million shares traded on a Friday before a May Bank holiday with a 10% rising share price. Not bad? |
US Payrolls missed, rate cut probability increased, indices rally. |
No doubt about it. America are buying in having been left out earlier in the day. |
I must say Harry that it's worth holding OXB just to get an education on what's going on in the pharmacy sector. Keep up the good work! |
We now have a high quality problem on our hands. I liken the recent movement in the share price to starting a very big fire at a tyre factory viz it is very visible and will attract attention from miles around. This could push the spike here quite high but it will then be interesting to see if a sudden fall sucks in more buyers. I seem to remember comment that shares were being issued at c.£4 at the time of the French acquisition: perhaps that a good starting point for genuine current share price value. |
I have no idea what is going on either, but it does remind me of a time when buying a few SCI at 270p, seeing them go to 330p. It was an illiquid stock and when a forced seller appeared, the MM's walked the price down to <50p. Once the seller dumped the final tranche, the price moved upwards rapidly almost hitting 700p. |
i would like to thank Harry for his posts.i am now back in profit having been looking at a big loss. Without those well informed posts i probably would have lost the faith. |
Is there more to this than a lovely set of results - if this was always worth 4-5 on worst case Harry, why did it ever get so low...I find this whole episode very odd. Perhaps it is simply the RR type scenario when the market gets too down on a great business?
back into an auction - unbelievable :) |
Wowza.... looking great.:) |
There has being a lot of pain watching the decline of OXB price over the last while.
My smile is widening by the minute... think we are all entitled to some sunshine .
Enjoy |
After the half year results, IM bought aggressively as part of their stated aim to get to 10% and that took the price rapidly to £3. As we know, they may not actually need to buy any more in the market to get to 10% once the EUR20m shares are issued later in the year.
It could be, if they are not currently inside on anything, that they have taken the view to aim to go beyond 10%? They were very clear before on their aims, but I don't think they'd need to announce any change to that in advance? |
Well done all 🍒🍒🍒 |
I'm intrigued to know what's driving this |
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders-DIVIDEND +5% -PORTFOLIO BROADENED THROUGH ACQUISITION |
I think we're all assuming OXB does the one step back at some point, but so far on the Friday of a bank holiday weekend when I'd normally expect a slow day - no sign of it.
FTSE quarterly review is the end of this month. 580p+ would be back in the FT250 and all sins forgiven. I honestly wasn't expecting that so soon after the results, but similarly if it did happen by some circumstance of events (like whatever is causing this movement and / or the insiders not buying) then it wouldn't surprise me either. |
I bet that DB note's been circulating for a few weeks, no wonder the price took off mid-April |
They want their clients to get in first :) |
SMALL CAP
----------
Deutsche Bank initiates Oxford BioMedica with ’hold’ - target 250 pence
----------
Well that's helpful. Best not mention the war eh? |
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
